Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Heparin Sodium

U.S. FDA Requirements: Heparin Sodium

Pharmaceutical / Drug Definition : Inhibits thrombus by preventing conversion of prothrombin to thrombin and fibrinogen to fibrin, preventing clot formation. Doesn't lyse existing clot, but prevents clot enlargement and extension.

Registrar Corp assists Heparin Sodium companies with:

  • FDA Registration Heparin Sodium
  • FDA Listing Heparin Sodium
  • FDA Label Requirements and Exceptions Heparin Sodium
  • FDA Import Information Heparin Sodium
  • FDA Detentions Heparin Sodium (Heparin Sodium Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Heparin Sodium (Heparin Sodium Suppliers)
       - Processors Heparin Sodium
       - Repackers Heparin Sodium
       - Relabelers Heparin Sodium
       - Exporters Heparin Sodium
       - Importers Heparin Sodium
For more information about Heparin Sodium, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco